Givaudan | GIVN - Gross Profit On Sales

Stock Price
2,790.00
Daily Change
-20.00 -0.71%
Monthly
3.26%
Yearly
-29.93%
Q2 Forecast
2,758.85

Givaudan reported CHF1.55B in Gross Profit on Sales for its fiscal semester ending in December of 2025.





Gross Profit On Sales Change Date
Air Liquide EUR 8.65B 4.44B Dec/2024
Akzo Nobel EUR 936M 102M Dec/2025
Anheuser-Busch USD 8.54B 91M Sep/2025
Arkema EUR 455M 14M Jun/2025
Associated British Foods GBP 382.5M 8.73B Dec/2024
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
British American Tobacco GBP 5.09B 6.36B Jun/2024
Covestro EUR 488M 64M Sep/2025
Croda International GBP 366.7M 183.1M Dec/2024
Danone EUR 6.82B 23M Dec/2024
Diageo GBP 6.39B 950M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.39B 147M Dec/2025
Givaudan CHF 1.55B 140M Dec/2025
Heineken EUR 3.16B 276M Dec/2024
International Flavors Fragrances USD 890M 93M Dec/2025
Johnson Matthey GBP 480M 33M Jun/2024
Kerry EUR 4.71B 656.3M Dec/2022
Lonza CHF 1.29B 248M Jun/2025
L'Oréal EUR 15.96B 822.8M Dec/2025
Merck EUR 2.96B 252M Dec/2025
Nestle CHF 21.43B 174M Dec/2024
Pernod Ricard EUR 3.11B 371M Dec/2025
Reckitt Benckiser GBP 4.25B 2.08B Dec/2024
SGS CHF 762.5M 48.5M Dec/2024
Sika AG CHF 3.02B 104.6M Dec/2025
Solvay EUR 265M 13M Sep/2025
Tate & Lyle GBP 902M 53M Jun/2023
Umicore EUR 308.6M 10.45M Dec/2024
Victrex GBP 68.3M 4M Dec/2025